HCG Near Me

Gloved hand holding a small vial with a blank label on a clinic desk

Sermorelin Side Effects: What Studies Report

Sermorelin

The side effects reported in sermorelin studies, what is not known, and what to ask your provider.

19 Nov 2026 • 6 mins read

The side effects most often reported with sermorelin are mild: facial flushing, and pain, redness or swelling where you inject. Published studies are small, though, and long-term safety data are limited. This guide sets out what the studies report, what nobody has measured, and what to ask your provider before you start.

This article is general information, not medical advice or a dose recommendation. Your prescribing provider decides whether sermorelin is right for you.

Usually mildFlushing and injection-site pain were the most common effects in the studies we found.
Small studiesThe adult trials had 11 and 19 people, so rare effects could be missed.
Ask about your historyCancer, pregnancy and pituitary conditions change the answer.

What are the side effects of sermorelin?

Sermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone, the signal that tells your pituitary gland to release growth hormone. It does not contain growth hormone itself. A review of sermorelin in children, published in BioDrugs, reports that single intravenous doses and repeated daily injections under the skin were well tolerated, and that transient facial flushing and pain at the injection site were the most commonly reported adverse events (PubMed 18031173).

Our own sermorelin guide lists what the clinic tells patients to expect: most effects are mild and local, such as redness, itching or swelling at the injection site, and less commonly flushing, headache, dizziness or feeling heavy at first. There is no current FDA label to check that list against, because there is no current FDA-approved sermorelin product.

What do the studies in adults report?

We found two small trials in older adults that report on safety. Neither used a modern compounded product, so treat them as background, not a guarantee.

StudyWhoTreatmentSafety finding
Metabolism, 1997 (PubMed 9005976)11 healthy men aged 64 to 76GHRH 1-29 injected nightly for 6 weeks“No significant adverse effects were observed.”
J Clin Endocrinol Metab, 1997 (PubMed 9141536)10 women and 9 men aged 55 to 71A GHRH 1-29 analog injected nightly for 16 weeks, after 4 weeks of placeboThe only adverse side effect was transient raised blood fats, which resolved by the end of the study.

Sources: the two PubMed abstracts linked in the table. The second trial used an analog of sermorelin, not sermorelin itself.

Both studies were small and short, so they cannot rule out rarer effects. They also studied older adults, not everyone who might be prescribed sermorelin. Our guide to sermorelin before and after covers what the same studies found about results.

What do reviews say about similar peptides?

A 2026 review in Frontiers in Endocrinology looked at peptides that act on the growth hormone and IGF-1 axis, a group that includes sermorelin. It lists adverse effects reported across the group, which span hormone and metabolic changes (including higher prolactin and cortisol, appetite changes and blood sugar problems), fluid retention, muscle and joint aches, and injection-site reactions (PubMed 42395176).

Keep the limits in mind. This is a narrative review of a whole group of peptides, many of them sold as unregulated “research compounds,” and it does not say which effect belongs to which peptide. It is a reason to ask questions, not a list of what sermorelin will do to you.

Does sermorelin cause cancer?

We found no study showing that it does. On 19 November 2026 we searched PubMed for sermorelin in the title or abstract together with cancer, neoplasm or tumor. The one result was a 2021 computer analysis of gene-expression data from glioma patients, which is not a trial and does not show that sermorelin causes or treats cancer (PubMed 33842627).

The 2026 review above describes mitogenic concerns, meaning concerns about cell growth, as “biologically plausible but unproven” for this group of peptides. So the honest answer is that the question is open. It is also why our sermorelin page says sermorelin is not appropriate with an active malignancy, and why your history matters before you start.

Are side effects different for men?

We found no study that reports sermorelin side effects separately by sex. One trial above enrolled only men and the other enrolled men and women, and neither describes a side effect that appeared in one sex only. If a website lists “sermorelin side effects in men” without citing a study, treat it as opinion.

Why is there no official list of side effects?

Because there is no current FDA-approved sermorelin product, there is no current FDA label to read. The brand-name version, Geref, was discontinued, and the FDA determined in 2013 that it was not withdrawn for safety or effectiveness reasons (Federal Register). Today’s sermorelin is compounded. The FDA says compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before they are marketed (FDA compounding questions and answers). Our article on whether sermorelin is FDA approved explains this in more detail.

What should you ask your provider?

  • Is it right for my history? Tell them about any cancer, pregnancy or breastfeeding, and pituitary or hormone conditions.
  • Which pharmacy compounds it? You should know where your medicine comes from.
  • What baseline bloodwork do you take, and when do you repeat it?
  • What should I watch for, and who do I call? Ask how quickly the team replies.
  • What happens if I get a side effect? Ask whether you pause, and who decides.
  • What are my other options? Our comparisons of sermorelin vs tesamorelin and ipamorelin vs sermorelin may help.

When should you call your provider?

Contact your provider if a side effect lasts, gets worse or worries you. Get urgent medical care for swelling of the face or lips, hives, trouble breathing, chest pain or fainting. Anyone can report a bad reaction to the FDA through MedWatch.

Frequently asked questions

What are the side effects of sermorelin?

In the studies we found, the most commonly reported were facial flushing and pain at the injection site. Our clinic page also lists redness, itching or swelling at the injection site, and, less often, headache, dizziness or feeling heavy at first. Two small trials in older adults reported no significant adverse effects or one temporary lab change.

Does sermorelin cause cancer?

We found no study showing that it does. A 2026 review of growth hormone-axis peptides calls mitogenic concerns, meaning concerns about cell growth, biologically plausible but unproven. Because the question is open, our clinic does not use sermorelin when someone has an active malignancy.

Are sermorelin side effects different in men?

We found no study that reports sermorelin side effects separately for men and women. One trial included only men and one included both sexes, and neither describes a sex-specific side effect.

Are there serious side effects of sermorelin?

The published trials we found did not report serious ones, but they were small and short. A 2026 review of similar peptides lists hormone changes, blood sugar changes and fluid retention as reported effects. Report anything severe to your provider, and get urgent care for swelling, hives or trouble breathing.

Do sermorelin side effects go away?

The common ones described in studies, flushing and injection-site pain, were transient. The one lab change in a 16-week trial, temporarily raised blood fats, resolved by the end of the study. Tell your provider what you feel and when it started.

Is sermorelin FDA approved?

No current sermorelin product is FDA-approved. The brand-name version, Geref, was discontinued, and today’s sermorelin is compounded. Read what FDA records show.

Next step

If you live in Miami and want a physician to review whether sermorelin suits your health history, start the free intake form. A physician reviews it, and the team contacts you to schedule your free appointment. You can also read our guide to getting sermorelin in Miami and our HGH peptides overview. The clinic is at 917 SW 87th Ave, Miami, FL 33174, and you can call (786) 724-1199 if you would rather talk it through first.

Sources

Scroll to Top
Call Now Button